跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
連結會在新分頁中打開
English
中文
在 臺北醫學大學 搜尋內容
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
全球衛生暨衛生安全博士學位學程
臺北醫學大學
公共衛生學院
電話
886-2-6638-2736#1285
電子郵件
[email protected]
網站
http://global.tmu.edu.tw/
郵寄地址
在地圖上顯示
概覽
指紋
網路
專家檔案
(16)
專案
(262)
研究成果
(2218)
資料集
(59)
指紋
查看啟用 全球衛生暨衛生安全博士學位學程 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
69%
Randomized Controlled Trial
60%
Cohort Analysis
39%
Odds Ratio
28%
Apoplexy
27%
Breast Cancer
24%
Disease
24%
Prevalence
23%
Infection
22%
Malignant Neoplasm
21%
Diabetes
17%
Chronic Kidney Disease
15%
Medicine
15%
Hazard Ratio
14%
COVID-19
13%
Injury
13%
Logistic Regression Analysis
12%
Multidrug Resistant Tuberculosis
12%
Health Care
12%
Brain Ischemia
11%
Health Care Cost
11%
Diabetes Mellitus
10%
Global Disease Burden
10%
Network Meta-Analysis
10%
Cesarean Section
9%
Cross Sectional Study
8%
Childbirth
8%
Symptom
8%
Drug Therapy
8%
Surgeon
7%
Adverse Event
7%
Mortality Rate
7%
Random Effects Model
7%
Lung Tuberculosis
7%
Low Birth Weight
7%
Quality of Life
7%
Asthma
7%
Postoperative Pain
7%
Proportional Hazards Model
6%
Case-Control Study
6%
Drug Resistant Tuberculosis
6%
Public Health
6%
Kidney Function
6%
Cohort Effect
6%
Ischemic Heart Disease
6%
Cancer Risk
6%
Cardiovascular Disease
6%
Premature Labor
6%
Quinolone Derivative
6%
Toxocariasis
5%
Retrospective Cohort Study
5%
Human Immunodeficiency Virus
5%
Maturity Onset Diabetes of the Young
5%
Patient-Data
5%
Small for Gestational Age
5%
Middle Age
5%
Traditional Chinese Medicine
5%
Antioxidant
5%
Body Mass Index
5%
Lung Cancer
5%
Migraine
5%
Hernioplasty
5%
Programmed Cell Death
5%
End Stage Renal Disease
5%
Tuberculosis Treatment
5%
Urinary System
5%
Effect Size
5%
Hepatocellular Carcinoma
5%
Cigarette Smoking
5%
Dietary Pattern
5%
Overall Survival
5%
Chronic Obstructive Pulmonary Disease
5%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
48%
Cohort Study
45%
Disease
34%
Malignant Neoplasm
30%
Prevalence
19%
Infection
18%
Breast Cancer
18%
Mouse
17%
Chronic Kidney Failure
16%
Adverse Event
14%
Diabetes Mellitus
11%
Injury
11%
Brain Ischemia
10%
Comorbidity
10%
Antivirus Agent
10%
Well Water
10%
Antioxidant
9%
Cigarette Smoking
9%
Rheumatoid Arthritis
8%
Cytotoxicity
8%
Chemotherapy
8%
Anti-Inflammatory Drug
8%
Neoplasm
8%
Multi-Drug-Resistant Tuberculosis
8%
Hepatitis C Virus
8%
Asthma
8%
Rifampicin
8%
Inflammation
8%
Global Disease Burden
7%
Liver Cell Carcinoma
7%
Non Insulin Dependent Diabetes Mellitus
7%
Low Birth Weight
7%
Overall Survival
7%
Antiinflammatory Activity
7%
Case-Control Study
7%
Symptom
7%
Mortality Rate
7%
Cardiovascular Disease
7%
Drug Resistant Tuberculosis
7%
Dose-Response Relationship
6%
Random Effects Model
6%
Quinolone Derivative
6%
Lipopolysaccharide
6%
Ischemic Heart Disease
6%
Transitional Cell Carcinoma
6%
Migraine
6%
Bladder Cancer
6%
Vaccination Policy
6%
Placebo
6%
HIV
6%
Tuberculostatic Agent
6%
Carotid Atherosclerosis
6%
Premature Labor
6%
Headache
5%
Lung Cancer
5%
Traditional Chinese Medicine
5%
IC50
5%
Cyclooxygenase 2
5%
Cytokine
5%
Small for Date Infant
5%
Survival Rate
5%
Hepatitis C
5%
Observational Study
5%
Inducible Nitric Oxide Synthase
5%
Hemodialysis
5%
Chronic Obstructive Lung Disease
5%
Nursing and Health Professions
Meta Analysis
74%
Confidence Interval
49%
Systematic Review
46%
Odds Ratio
24%
Cohort Analysis
21%
National Health Insurance
20%
Breast Cancer
16%
Disease
14%
Quality of Life
13%
Health Care Personnel
13%
Health Service
13%
Practice Guideline
12%
Hospital
12%
Logistic Regression Analysis
11%
Prevalence
11%
Drug Therapy
11%
Cochrane Library
11%
Cross-Sectional Study
10%
Medline
10%
Injury
9%
Symptom
9%
World Health Organization
9%
Health Literacy
8%
Hazard Ratio
7%
Comorbidity
7%
Malignant Neoplasm
7%
Human Immunodeficiency Virus
7%
Traumatic Brain Injury
7%
Shared Decision-Making
6%
Pregnancy Outcome
6%
Mortality Rate
6%
Long Term Care
6%
Embase
6%
Outpatient
6%
Rehabilitation Engineering
6%
Infection
6%
Health Status
5%
Limb Injury
5%
Mental Health
5%
Low Birth Weight
5%
Adverse Event
5%
Teaching Hospital
5%
Multivariate Logistic Regression Analysis
5%
Supplementation
5%
Healthcare System
5%
Rheumatoid Arthritis
5%
Health Care Utilization
5%
Public Hospital
5%
Pilot Study
5%